Communiqués

11/08 Peptonic Medical AB announces change in the board AQ
24/06 Bulletin from the annual general meeting in Peptonic Medical AB (publ) AQ
24/06 Peptonic Medical AB Presents Nominations for Board Members Ahead of the Annual General Meeting on June 24, 2026 AQ
15/06 Peptonic receives approximately SEK 7.5 million through warrants of series TO6 AQ
10/06 Peptonic Medical AB publishes its Annual Report for the 2025 financial year AQ
10/06 Peptonic Medical completes first delivery to strategic US partner - a key milestone in the company's international expansion AQ
09/06 The last day of trading with the warrants of series TO6 in Peptonic Medical AB is today, June 9, 2026 AQ
08/06 Peptonic Medical AB - Major shareholder exercises warrants to subscribe for shares AQ
04/06 Peptonic Medical AB announces a new date for the publication of its annual report AQ
03/06 Peptonic Medical launches a new product segment in health and beauty - strengthening growth opportunities through a broader offering and a new brand AQ
01/06 Peptonic Medical: The subscription price for warrants of series TO6 in Peptonic has been determined to SEK 0.0011 and the exercise period begins today PU
01/06 The subscription price for warrants of series TO6 in Peptonic has been determined to SEK 0.0011 and the exercise period begins today AQ
29/05 Peptonic Medical nears first delivery to strategic partner in the US - a key milestone in its international expansion AQ
27/05 Peptonic Medical AB (publ) - Publishes financial report for the first quarter 2026 AQ
26/05 NOTICE OF THE ANNUAL GENERAL MEETING OF PEPTONIC MEDICAL AB AQ
22/05 Peptonic Medical Launches VagiVital Moisturizing Intimate Cream, Further Expanding Its Portfolio of Moisturizing Intimate Care Products AQ
20/05 Peptonic Medical is expanding its portfolio in the intimate self-care category and launching VagiVital Intimate V Wipes AQ
19/05 Peptonic postpones the Annual General Meeting and publication of the annual report AQ
28/04 Peptonic provides an update on Vernivia AQ
27/02 Peptonic Medical () : Publishes Year-end report for 2025 PU
27/02 Peptonic Medical AB (publ) - Publishes Year-end report for 2025 AQ
26/02 Peptonic Medical AB - Board of Directors appoints Daniel Rudeklint as interim CEO AQ
25/02 Peptonic Medical AB announces termination of liquidity provider agreement AQ
18/02 Peptonic announces the last day of trading in BTU and first day of trading in TO6 warrants AQ
12/02 PEPTONIC medical : Board of Directors resolves on a directed issue of units to guarantors in connection with the completed rights issue PU
Aucun résultat pour cette recherche